Seoul Pharma Co., Ltd (KOSDAQ:018680)
South Korea
· Delayed Price · Currency is KRW 2,790.00
-55.00 (-1.93%)
At close: Apr 29, 2026
Seoul Pharma Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 753.64 | 1,699 | 3,517 | 855.09 | -9,689 | Upgrade
|
| Depreciation & Amortization | 2,662 | 2,490 | 1,928 | 2,613 | 2,528 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.78 | 0.05 | 8.26 | 0.02 | 0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 2,177 | 198.8 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -67.49 | -63.71 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 24.64 | -14.53 | -6.14 | -9.64 | 24.12 | Upgrade
|
| Other Operating Activities | 944.03 | 1,549 | 2,270 | -207.94 | 4,898 | Upgrade
|
| Change in Accounts Receivable | 631.55 | -4,071 | -111.42 | -381.62 | -1,261 | Upgrade
|
| Change in Inventory | 523.9 | -1,623 | -1,920 | -2,769 | 270.5 | Upgrade
|
| Change in Accounts Payable | -469.53 | -410.48 | -164.12 | 1,020 | 1,173 | Upgrade
|
| Change in Other Net Operating Assets | -3,186 | -2,559 | -193.42 | -3,375 | 181.78 | Upgrade
|
| Operating Cash Flow | 1,886 | -3,008 | 5,265 | -78.21 | -1,675 | Upgrade
|
| Capital Expenditures | -861.26 | -2,229 | -1,893 | -1,233 | -1,157 | Upgrade
|
| Sale (Purchase) of Intangibles | -32.46 | -0.7 | -1.52 | -66.23 | -10.71 | Upgrade
|
| Investment in Securities | - | 3,146 | -4,023 | - | 3.18 | Upgrade
|
| Other Investing Activities | 50.75 | 540.74 | 55 | -33 | 1 | Upgrade
|
| Investing Cash Flow | -842.97 | 1,457 | -5,862 | -1,332 | -1,099 | Upgrade
|
| Short-Term Debt Issued | 2,000 | 3,000 | - | 4,000 | 4,000 | Upgrade
|
| Long-Term Debt Issued | - | 10,000 | - | - | 10,000 | Upgrade
|
| Total Debt Issued | 2,000 | 13,000 | - | 4,000 | 14,000 | Upgrade
|
| Short-Term Debt Repaid | - | - | -4,000 | -4,000 | -2,000 | Upgrade
|
| Long-Term Debt Repaid | -672.39 | -10,620 | -465.7 | -474.25 | -10,465 | Upgrade
|
| Total Debt Repaid | -672.39 | -10,620 | -4,466 | -4,474 | -12,465 | Upgrade
|
| Net Debt Issued (Repaid) | 1,328 | 2,380 | -4,466 | -474.25 | 1,535 | Upgrade
|
| Other Financing Activities | -0 | -0 | - | -8.94 | -0 | Upgrade
|
| Financing Cash Flow | 1,328 | 2,380 | -4,466 | -483.19 | 1,535 | Upgrade
|
| Foreign Exchange Rate Adjustments | 38.05 | 138.15 | -91.7 | -198.35 | 1.74 | Upgrade
|
| Net Cash Flow | 2,408 | 966.43 | -5,155 | -2,092 | -1,237 | Upgrade
|
| Free Cash Flow | 1,025 | -5,237 | 3,372 | -1,311 | -2,831 | Upgrade
|
| Free Cash Flow Margin | 1.97% | -9.78% | 6.43% | -2.62% | -7.00% | Upgrade
|
| Free Cash Flow Per Share | - | -449.20 | 289.20 | -146.00 | -332.16 | Upgrade
|
| Cash Interest Paid | 570.07 | 427.49 | 442.51 | 491.88 | 457.9 | Upgrade
|
| Cash Income Tax Paid | 188.68 | 11.53 | 4.36 | 31.28 | 165.54 | Upgrade
|
| Levered Free Cash Flow | -5.64 | -7,405 | -524.76 | -2,459 | 1,277 | Upgrade
|
| Unlevered Free Cash Flow | 355.16 | -7,129 | -248.19 | -1,757 | 1,984 | Upgrade
|
| Change in Working Capital | -2,500 | -8,663 | -2,389 | -5,506 | 364.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.